PRODUCT DESCRIPTION
Tesamorelin is a stabilized growth hormone-releasing peptide with one of the strongest human research histories in its category. It encourages natural GH pulses and downstream IGF-1 production. Researchers have examined its potential to reduce visceral fat, improve body composition, influence liver fat and lipid metabolism, and support selected cognitive and inflammatory outcomes.
Potential research benefits
- Reduction of deep abdominal fat: Tesamorelin is especially well known for human research showing meaningful decreases in visceral fat surrounding the internal organs.
- Improved body composition: Researchers have studied changes in waist size, fat distribution, lean tissue, and the overall balance between fat and muscle.
- Support for liver health: Trials have reported encouraging reductions in liver fat and improvements in measurements connected with fatty-liver research.
- Natural growth hormone stimulation: Tesamorelin encourages pulsatile GH release and downstream IGF-1 production rather than supplying growth hormone directly.
- Wider metabolic and cognitive interest: Scientists are also exploring possible effects on cholesterol, inflammation, brain function, and the metabolic consequences of excess visceral fat.
Why researchers are interested
Controlled human trials have reported meaningful reductions in visceral abdominal fat along with changes in body composition and liver-related markers. These results have made tesamorelin an important compound for studying the relationship between the GH axis and metabolically active visceral fat.